Latest Capital Raises News

Bass Oil has secured full ownership of the Vanessa gas field in the Cooper Basin, aiming to resume gas sales by year-end after recommissioning the facility and pipeline.

Perpetual Resources (ASX: PEC) has locked in a 100% stake in the historic Nevada Scheelite tungsten mine, boasting an average grade of 1.1% WO3 and existing underground infrastructure. The acquisition is backed by a $2.5 million placement to fund validation and exploration.

Novonix has secured A$20.7 million from an institutional placement at a 33% discount, alongside a A$3 million Share Purchase Plan for existing shareholders, aiming to fund production capacity expansion amid growing battery demand.

Patagonia Lithium’s Well 7 at Formentera delivered a lithium assay of 270ppm at 282m, close to the project average, alongside encouraging porosity and specific yield results that underpin production potential. Drilling will now shift to the Cilon concession, targeting a high-grade lithium zone.

Zinc of Ireland (ASX: ZMI) has finalised its acquisition of Meclex, securing two hydrometallurgical technologies aimed at disrupting zinc and lead processing with low-emission methods. Backed by a fresh A$5.5 million placement, ZMI is accelerating pilot plant development and exploration at its Kildare project.

St George Mining has raised A$60 million through a two-tranche placement led by major shareholder Hancock Prospecting to accelerate development of its high-grade Araxá rare earths and niobium project in Brazil.

Stealth Group Holdings has posted record preliminary FY26 results, driven by strong organic growth and the transformative acquisition of Hardware & Building Traders (HBT). The company remains on track for its ambitious FY28 sales and EBITDA margin targets.

Bounty Oil & Gas has finalised the first tranche of a $4 million share placement and converted $200,000 of debt into shares, bolstering its capital for drilling and development across Australian oil and gas projects.

ALS Limited has confirmed its ordinary dividend of AUD 0.231 per share for the six months ending March 2026, introducing multi-currency payment options and appointing Macquarie Securities to manage on-market share purchases for its Dividend Reinvestment Plan.

Racura Oncology has raised $34.3 million through shareholder-backed initiatives, securing funding for its lead asset RC220’s clinical trials in AML, EGFRm lung cancer, and cardioprotection in solid tumour patients.

Hydrix Limited has secured $5.22 million from its retail entitlement offer, leaving nearly $3 million in entitlements unsold, which will be offered separately under a shortfall offer managed by Peak Asset Management.

Spenda Limited has launched the retail component of its $8.545 million accelerated entitlement offer, aiming to recapitalise, reduce debt, and support product development. Eligible shareholders can subscribe for 7 new shares per existing share, with free attaching options exercisable until 2031.